Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $212.81 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $189.13 | 7 | $0 (2021) |
| AbbVie Inc. | $12.90 | 1 | $0 (2021) |
| Allergan Inc. | $10.78 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $80.94 | 3 | PFIZER INC. ($68.04) |
| 2020 | $73.35 | 2 | PFIZER INC. ($73.35) |
| 2018 | $28.32 | 2 | PFIZER INC. ($28.32) |
| 2017 | $30.20 | 2 | PFIZER INC. ($19.42) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/05/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $35.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $35.98 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/18/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $37.37 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/18/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/22/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/28/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: NEUROSCIENCE | ||||||
| 02/03/2017 | PFIZER INC. | CHANTIX (Drug), VIAGRA, ELIQUIS | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 96 | 121 | $14,910 | $3,949 |
| 2020 | 11 | 390 | 811 | $98,974 | $41,839 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 72 | $9,000 | $2,610 | 29.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 22 | $4,290 | $1,122 | 26.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 24 | 27 | $1,620 | $216.79 | 13.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 105 | 299 | $37,375 | $16,090 | 43.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 65 | 104 | $20,280 | $8,852 | 43.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 116 | $14,820 | $7,172 | 48.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 27 | $6,750 | $3,034 | 44.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 16 | 23 | $5,175 | $2,743 | 53.0% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 55 | 87 | $5,220 | $1,361 | 26.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 16 | 21 | $3,150 | $1,313 | 41.7% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 11 | 12 | $1,560 | $536.08 | 34.4% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 37 | 56 | $3,324 | $535.17 | 16.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 41 | 53 | $1,060 | $158.70 | 15.0% |
| 81002 | Urinalysis, manual test | Office | 2020 | 13 | 13 | $260.00 | $45.17 | 17.4% |
About Dr. John Gnap, MD
Dr. John Gnap, MD is a Mental Health healthcare provider based in Chicago Ridge, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164572319.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Gnap, MD has received a total of $212.81 in payments from pharmaceutical and medical device companies, with $80.94 received in 2021. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($212.81).
As a Medicare-enrolled provider, Gnap has provided services to 486 Medicare beneficiaries, totaling 932 services with total Medicare billing of $45,789. Data is available for 2 years (2020–2021), covering 14 distinct procedure/service records.
Practice Information
- Specialty Mental Health
- Other Specialties Addiction Medicine
- Location Chicago Ridge, IL
- Active Since 01/11/2007
- Last Updated 03/30/2010
- Taxonomy Code 101YM0800X
- Entity Type Individual
- NPI Number 1164572319
Products in Payments
- CHANTIX (Drug) $109.44
- ELIQUIS (Drug) $79.69
- UBRELVY (Drug) $12.90
- VRAYLAR (Drug) $10.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.